QL
UTHR icon

Quarry LP’s United Therapeutics UTHR Stock Holding History

Quarry LP’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63K Buy
+3
New +$1.69K ﹤0.01% 1748
2026
Q1 		– Sell
-550
Closed -$268K – 2271
2025
Q4 		$268K Buy
+550
New +$256K 0.04% 232

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Quarry LP's UTHR Position: Q2 2026 in Review

Quarry LP opened a new position in United Therapeutics (UTHR) in Q2 2026: 3 shares worth $1.63K. The stake represents ﹤0.01% of the portfolio and ranks #1748 among its holdings. This is a return to the name: Quarry LP previously reported a position in UTHR as recently as Q4 2025.

Quarry LP first reported a position in UTHR in Q4 2025 and has held it in 2 quarters since. The position peaked at $268K in Q4 2025. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Quarry LP held 3 shares of United Therapeutics worth $1.63K as of Q2 2026.
  • United Therapeutics was a new Quarry LP position in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1748 holding.
  • Quarry LP first reported a position in United Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Quarry LP's United Therapeutics position peaked at $268K in Q4 2025.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.